UmbriaExplore our travel guides. Share your stories, tips and questions on Reddit.
Fast movers • Alerts • Momentum
10% OFF with SAVE10
Charts • Watchlists • Multi-broker tools
Built for active traders
Biotech catalyst, news and analysis PDUFA tracker
Biotech catalyst, news and analysis PDUFA tracker
Last updated: October 18, 2026
A stock hub is the home page of a single company: what it does, where the programme or the contract stands, how much cash the latest filing reports, which dates can change the picture and where the risk sits. Every hub starts here, by sector or by searching a ticker or a company name. Educational and informational research, not investment advice.
312 stock hubs across 5 sectors plus other coverage, plus the calendars, briefings and educational pages that sit next to them.
The largest branch of the site. Each hub holds the pipeline, the endpoints of the trial under way, the cash reported in the latest filing, the dilution risk and the dates that can move the stock in a single session.
Open the Biotech and healthcare indexLaunch vehicles and constellations, tactical drones, optics and compute infrastructure. Here the catalyst is not an FDA date: it is a contract award, a launch window, a backlog turning into revenue.
Open the Space, defense and AI indexWho mines, who refines, who sells the electricity. Permits, offtake agreements, separation capacity and the cost of capital matter as much as the commodity price.
Open the Energy, critical minerals and rare earths indexThe regulatory thread read through the companies listed in the United States and Canada, with cash and capital structure set beside the expectations on federal reform.
Open the Cannabis indexCapacity, load factor, unit revenue, RevPAR, residual fleet values and balance sheet leverage. The sector where the numbers are read per unit before they are read per share.
Open the Travel indexHubs on companies that do not belong to any of the five sector indexes and are reachable only from this page.
Back to searchConfirmed dates from primary sources: PDUFA, AdCom, readouts, regulatory deadlines.
The running selection of the ten biotech names in focus.
The weekly read: verified events, catalysts, earnings, watchlist.
Session context, sector rotation, pressure on the tape.
Deep dives, radars, sector updates and single-name reports.
The tools behind the research: where filings, trials and FDA decisions are read.
Form 4 buys and sells recomputed lot by lot, against what the screeners report.
The travel channel, kept separate from the equity research.
The date that matters, with the hour and the time zone when the company states them, and next to it the binary event or the capital raise.
Market capitalization, shares, float, short interest, institutional and insider ownership, analyst targets: every figure carries its own date.
Revenue, net loss, the cash reported in the latest filing, debt, the dilution history.
Where each programme or contract stands, what is still to be funded, where the execution risk concentrates.
The two opposing readings written out in full, without choosing for the reader.
SEC filings, official press releases, FDA, EMA, ClinicalTrials.gov, with a link to the document.
